Identification of genomic biomarkers of disease progression and survival in primary CNS lymphoma.

Blood Adv · 2025 · PMC11914178 · PMID 39536287

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantP = 5.8e−6actually significant

The highly significant correlation between genomic aberrations involving 6p CN-LOH/6p21.3 HD/ BTG1 / ETV6/TP53 and shorter PFS (HR, 5.5; P = 5.8e−6) and OS (HR, 3.7; P = .0075) was also observed in the cohort of 54 prospectively profiled patients at time of biopsy ( supplemental Figure 9 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.